One thing you can say is that the stock has performed well this year relative to the rest of the market even though the business hasn’t delivered revenue on the test yet.
Ann: UK NICE publishes Medtech Innovation Briefing on PromarkerD, page-7
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
70.0¢ |
Change
0.010(1.45%) |
Mkt cap ! $91.70M | |||
| Open | High | Low | Value | Volume |
| 69.0¢ | 70.5¢ | 68.5¢ | $29.16K | 41.85K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 12777 | 70.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 71.0¢ | 20000 | 1 |
View Market Depth
| Last trade - 15.12pm 08/11/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |